U.S. Markets close in 4 hrs 17 mins

Illumina, Inc. (ILMN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
175.91+2.15 (+1.24%)
At close: 4:00PM EDT
People also watch
ALXNREGNBIIBVRTXCELG
Interactive chart
Previous Close173.76
Open174.01
Bid172.25 x 1000
Ask183.99 x 100
Day's Range173.80 - 177.10
52 Week Range119.37 - 189.48
Volume912,507
Avg. Volume1,015,760
Market Cap25.68B
Beta1.20
PE Ratio (TTM)35.60
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 5 Top Healthcare Technology Trends That Could Make You Rich
    Motley Fool4 days ago

    5 Top Healthcare Technology Trends That Could Make You Rich

    These stocks could be just the ticket to profit from the top healthcare technology trends.

  • Start-up Genome Medical is training experts to help you figure out what your genetic tests mean
    CNBC6 days ago

    Start-up Genome Medical is training experts to help you figure out what your genetic tests mean

    A new technology startup called Genome Medical has a plan to address the shortage of genetic counselors.

  • American City Business Journals14 days ago

    Blood money: Peninsula liquid biopsy company gets $360M injection

    In the billion-dollar race to come up with the best way of detecting cancer by peering closely at the blood, a Redwood City company Wednesday said that it raised $360 million on its way to a potential initial public offering. Guardant Health Inc. said the round was led by a subsidiary of Japanese telecommunications company SoftBank Group and included Sequoia Capital, Khosla Ventures, Lightspeed Venture Partners, OrbiMed and 8VC as well as accounts managed by T. Rowe Price and Singapore's Temasek. The mix of traditional venture capital and crossover investors — typically private equity groups that often look to take companies public soon after their investments — hints at an IPO for four-year-old Guardant, especially since liquid biopsies have garnered lots of attention for their potential of detecting cancer early.